Molecular detection and characterization of methicillin-resistant Staphylococcus pseudintermedius (MRSP) ST2361 in a healthcare setting

在医疗机构中对耐甲氧西林中间葡萄球菌(MRSP)ST2361进行分子检测和表征

阅读:1

Abstract

BACKGROUND: Staphylococcus pseudintermedius, a commensal in dogs, is an emerging zoonotic pathogen with increasing methicillin-resistant (MRSP) strains. This study investigated MRSP isolates from hospital environments and healthcare workers in Bojnurd, Iran, to assess antimicrobial resistance and zoonotic potential. METHODS: Nasal swabs from healthcare workers (n = 40) and hospital supplies (n = 35) were cultured. Phenotypic and genotypic analyses included antimicrobial susceptibility testing (Kirby-Bauer), PCR for resistance (mecA, vanA, cfr) and virulence genes (pvl, hla, icaA/D), SCCmec typing, and multilocus sequence typing (MLST). RESULTS: Two MRSP isolates (ST2361) were identified, one from a nasal swab and another from hospital supplies. Both exhibited resistance to β-lactams (cefoxitin, penicillin), fluoroquinolones, macrolides, and sulfonamide-trimethoprim, but susceptibility to tetracyclines, gentamicin, linezolid, and vancomycin. PCR confirmed mecA and virulence genes (pvl, hla, icaA/D). A SCCmec pattern consistent with type IV and identical ST2361 profiles suggested potential clonal relatedness. CONCLUSION: The presence of MRSP ST2361 in humans and hospital environments highlights its zoonotic and nosocomial transmission risks. The isolates' multidrug resistance and virulence genes underscore the need for improved diagnostics, antimicrobial stewardship, and infection control measures in healthcare settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。